Cizzle Biotechnology Holdings PLC

Research Cizzle Biotechnology Holdings PLC (CIZ) on Bullrun: market cap GBX 10.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCIZ
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 10.96M
• Financial periodFY2024
• Net income-GBP 2.17M
• Free cash flow-GBP 358.00K

Valuation Snapshot

latest market cap is GBX 10.96M.

About Cizzle Biotechnology Holdings PLC

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Frequently asked questions

What is Cizzle Biotechnology Holdings PLC's market cap?

Cizzle Biotechnology Holdings PLC's market capitalization is GBX 10.96M.

What does Cizzle Biotechnology Holdings PLC do?

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology.